Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by MR Schaafsma
Highly Purified CD34+ Cells Isolated Using Magnetically Activated Cell Selection Provide Rapid Engraftment Following High-Dose Chemotherapy in Breast Cancer Patients
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Effective T Cell Regeneration Following High-Dose Chemotherapy Rescued With CD34+ Cell Enriched Peripheral Blood Progenitor Cells in Children
Bone Marrow Transplantation
Transplantation
Hematology
Isolation and Transplantation of Autologous Peripheral CD34+ Progenitor Cells Highly Purified by Magnetic-Activated Cell Sorting
Bone Marrow Transplantation
Transplantation
Hematology
High-Dose Chemotherapy in High-Risk Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Subclinical Cardiotoxicity Following Adjuvant Dose-Escalated FEC, High-Dose Chemotherapy, or CMF in Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Factors Predicting Engraftment of Autologous Blood Stem Cells: CD34+ Subsets Inferior to the Total CD34+ Cell Dose
Bone Marrow Transplantation
Transplantation
Hematology
High-Dose Chemotherapy (CTM) for Breast Cancer
Bone Marrow Transplantation
Transplantation
Hematology
Is High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation in Breast Cancer Patients a Done Deal?
Women's Health
Medicine
Occult Tumor Cell Contamination in Patients With Stage II/III Breast Cancer Receiving Sequential High-Dose Chemotherapy
Bone Marrow Transplantation
Transplantation
Hematology
A Longitudinal Prospective Study of Health-Related Quality of Life in Breast Cancer Patients Following High-Dose Chemotherapy With Autologous Blood Stem Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
